IP Library Granted Patent US 10,455,817
Granted Patent B2
US 10,455,817 · App. 15/284,817 · Granted Oct 29, 2019

Animal olfactory detection of disease as control for health metrics collected by medical toilet

Inventors: David R. Hall (Provo, UT); Joe Fox (Spanish Fork, UT); Terrece Pearman (Draper, UT)
Assignee: Hall Labs LLC
A01K29/005A61B5/150045A61B10/007A61B10/0038A61B10/0051A61B10/0058A61B10/0064G01N33/0027G01N33/483A61B2010/0061A61B2010/0067A61B2010/0074A61B2010/0087
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,455,817
App. No.
15/284,817
Granted
Oct 29, 2019
Kind
B2
Abstract

We disclose a medical toilet that comprises one or more medical devices and a control for the metrics they collect. The medical devices may be used to collect metrics relevant to a user's health status. The medical toilet further comprises a conduit through which volatile organic compounds travel from the toilet bowl to the environment outside the toilet. An animal trained to identify the scent of bodily waste collected from a user that is afflicted with a disease perceives the scent of the user's bodily waste traveling through the conduit and performs a defined act upon perceiving the disease scent. The metric collected by the medical device(s) may be used to diagnose the same disease as that which the animal is trained to identify. The diagnosis provided by the animal by way of the conduit acts as a control for the metric collected by the medical device.

Claims (77)

1. A method of providing a control for a first health metric collected by a medical toilet for use in diagnosing a disease in a user comprising the steps of:

providing a medical toilet, the toilet comprising:

a toilet bowl;

a toilet seat;

a medical device which measures a first health metric, wherein the first health metric is an indicator of the disease in a user;

a scent dispenser, the scent dispenser comprising:

an opening within a side of the toilet;

wherein the opening is defined by a frame, the frame comprising a first side in communication with an environment outside the toilet bowl and a second side in communication with an environment inside the toilet bowl;

wherein the opening connects the environment inside the toilet bowl with the environment outside the toilet bowl; and

wherein the opening defines a conduit to transfer volatile organic compounds from the toilet bowl to the environment outside the toilet;

providing an animal, wherein the animal is trained to:

smell the air being emitted from the scent dispenser;

identify a scent that is associated with the disease; and

perform a defined act when the animal perceives scent associated with the disease; and

depositing one or more types of bodily waste from the user into the medical toilet, wherein the bodily waste emits one or more volatile organic compound;

collecting the first health metric using the medical device of the medical toilet;

placing the animal proximate to the scent dispenser; and

recording the behavior of the animal which comprises either performance or nonperformance of the defined act;

wherein the first health metric measured by the medical device and the scent identified by the animal are indicators of the same disease;

wherein the medical device collects a first health metric by measuring a property of a different physiological function of the disease than the bodily waste that the animal and scent dispenser analyses;

wherein the medical device provides a quantitative assessment of the disease and the animal provides a control by providing a qualitative assessment of the disease.

2. The method of claim 1 , wherein the bodily waste comprises one or more of the following: urine, feces, vomit, sputum, blood, seminal fluid, tears, nasal mucus, gastrointestinal tract mucus, urogenital tract mucus, saliva, exhaled breath, or sweat.

3. The method of claim 1 , further comprising collection of a follow-up health metric, wherein the follow-up health metric measures an indicator of the disease.

4. The method of claim 3 , wherein the follow-up health metric is performed when the first health metric and the behavior of the animal indicate conflicting diagnosis of the disease in the user.

5. The method of claim 1 , wherein a follow-up health metric comprises a measurement of an analyte present in or emitted from the one or more types of bodily waste.

6. The method of claim 1 , wherein the disease is selected from one or more of the following:

colon adenoma, colon carcinoma, colon adenocarcinoma, colorectal adenoma, colorectal carcinoma, colorectal adenocarcinoma, bladder carcinoma, bladder adenocarcinoma, liver adenoma, liver carcinoma, liver adenocarcinoma, esophageal adenoma, esophageal carcinoma, esophageal adenocarcinoma, stomach adenoma, stomach carcinoma, stomach adenocarcinoma, pancreatic adenoma, pancreatic carcinoma, pancreatic adenocarcinoma, lung cancer, mouth cancer, throat cancer, inflammatory bowel disease, urinary tract infection, gastric ulcer, diabetes, hyperglycemia, hypoglycemia, impending seizure, and impending migraine.

7. The method of claim 1 , wherein the disease consists of cancer.

8. The method of claim 1 , wherein the defined action is selected from one or more of the following:

emitting a sound, tail wagging, assuming a sitting position, assuming supine position, pointing, tapping the scent dispenser with the animal's nose, tapping the scent dispenser with the animal's paw, tapping a human with the insect's or rodent's nose, tapping a human with the animal's paw, moving in circles, raising a proboscis, and vibrating.

9. A method of diagnosing a disease in a user, wherein the disease is associated with a disease process that causes the user to excrete bodily waste comprising at least one volatile organic compound that is not detectable by smell in bodily waste collected from a user not afflicted with the disease, the method comprising the steps of:

providing a medical toilet, the medical toilet comprising:

a toilet bowl, the toilet bowl housing a volume of toilet water;

a toilet seat;

a medical device, wherein the medical device collects a first health metric to identify the presence of a disease in a user;

a scent dispenser, the scent dispenser comprising:

an opening within a side of the medical toilet;

wherein the opening is defined by a frame, the frame comprising a first side in communication with an environment outside the toilet bowl and a second side in communication with an environment inside the toilet bowl;

wherein the opening connects the environment inside the toilet bowl with the environment outside the toilet bowl; and

wherein the opening defines a conduit to transfer volatile organic compounds from the environment inside toilet bowl to the environment outside the toilet;

providing an insect or rodent, wherein the insect or the rodent is trained to:

identify a scent that is associated with the disease; and

perform a defined act when the insect or the rodent perceives the scent associated with the disease;

depositing one or more types of bodily waste from the user into the medical toilet, wherein the bodily waste emits one or more volatile organic compounds;

collecting the first health metric using the medical toilet;

placing the insect or the rodent proximate to the scent dispenser; and

recording the behavior of the insect or the rodent which comprises either performance or nonperformance of the defined act;

wherein the first health metric measured by the medical device and the scent identified by the animal are indicators of the same disease;

wherein the medical device collects a first health metric by measuring a property of a different physiological function of the disease than the bodily waste that the animal and scent dispenser analyses;

wherein the medical device provides a quantitative assessment of the disease and the animal provides a control by providing a qualitative assessment of the disease.

10. The method of claim 9 , wherein the bodily waste comprises one or more of the following: urine, feces, vomit, sputum, blood, seminal fluid, tears, nasal mucus, gastrointestinal tract mucus, urogenital tract mucus, saliva, exhaled breath, or sweat.

11. The method of claim 9 , further comprising collection of a follow-up health metric, wherein the follow-up health metric measures an indicator of the disease.

12. The method of claim 11 , wherein the follow-up health metric is performed when the first health metric and the behavior of the animal indicate a conflicting diagnosis of the disease in the user.

13. The method of claim 9 , wherein a follow-up health metric comprises the measurement of an analyte present in or emitted from the one or more types of bodily waste.

14. The method of claim 9 , wherein the disease is selected from one or more of the following:

colon adenoma, colon carcinoma, colon adenocarcinoma, colorectal adenoma, colorectal carcinoma, colorectal adenocarcinoma, bladder carcinoma, bladder adenocarcinoma, liver adenoma, liver carcinoma, liver adenocarcinoma, esophageal adenoma, esophageal carcinoma, esophageal adenocarcinoma, stomach adenoma, stomach carcinoma, stomach adenocarcinoma, pancreatic adenoma, pancreatic carcinoma, pancreatic adenocarcinoma, lung cancer, mouth cancer, throat cancer, inflammatory bowel disease, urinary tract infection, gastric ulcer, diabetes, hyperglycemia, hypoglycemia, impending seizure, and impending migraine.

15. The method of claim 9 , wherein the disease consists of cancer.

16. The method of claim 9 , wherein the defined act is selected from one or more of the following: emitting a sound, tail wagging, assuming a sitting position, assuming supine position, pointing, tapping the scent dispenser with the animal's nose, tapping the scent dispenser with the animal's paw, tapping a human with the animal's nose, tapping a human with the animal's paw, moving in circles, raising a proboscis, and vibrating.

17. A method of providing a control for a first health metric collected by a medical toilet for use in diagnosing a disease in a user comprising the steps of:

providing a medical toilet, the toilet comprising:

a toilet bowl;

a toilet seat;

a medical device which measures an analyte in the bodily waste of a user to obtain a first health metric, wherein the first metric is an indicator of the disease in a user;

a scent dispenser, the scent dispenser comprising:

an opening within a side of the toilet;

wherein the opening is defined by a frame, the frame comprising a first side in communication with an environment outside the toilet bowl and a second side in communication with an environment inside the toilet bowl;

wherein the opening connects the environment inside the toilet bowl with the environment outside the toilet bowl; and

wherein the opening defines a conduit to transfer volatile organic compounds from the toilet bowl to the environment outside the toilet;

providing an animal, wherein the animal is trained to:

smell the air being emitted from the scent dispenser;

identify a scent that is associated with the disease; and

perform a defined act when the animal perceives scent associated with the disease; and

depositing one or more types of bodily waste from the user into the medical toilet, wherein the bodily waste emits one or more volatile organic compound;

collecting the first health metric by measuring an analyte in the bodily waste of a user using the medical toilet;

placing the animal proximate to the scent dispenser; and

recording the behavior of the animal which comprises either performance or nonperformance of the defined act;

wherein the first health metric measured by the medical device and the scent identified by the animal are indicators of the same disease.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 14, 2020
From: HALL LABS LLC
To: MEDIC, INC.
Reel/Frame 052671/0795 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 15, 2018
From: FOX, JOE
To: HALL LABS LLC
Reel/Frame 046832/0440 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 15, 2018
From: PEARMAN, TERRECE
To: HALL LABS LLC
Reel/Frame 046834/0374 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 15, 2018
From: HALL, DAVID R
To: HALL LABS LLC
Reel/Frame 046832/0478 →
Continuity (1)
Related Publication 20180092335A1 · Apr 5, 2018
Cited By (3)
US 12,251,991 US 12,269,315 US 12,377,711